Real-time enrollment status for this glioblastoma (gbm) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:45 AM UTC
| NCT Number | NCT07185880 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma (GBM) |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Myosin Therapeutics Inc. |
| Last Updated on CT.gov | April 14, 2026 (Apr 14, 2026) |
As of July 13, 2026: Clinical trial NCT07185880 is currently recruiting participants. This clinical trial study for glioblastoma (gbm) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Myosin Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07185880 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07185880 was last updated Apr 14, 2026 (April 14, 2026). HelloStudys verifies this status automatically.